AAD 2026Abstract 76623
Long-term (up to 104 weeks) maintenance of itch and skin responses with nemolizumab treatment in patients with moderate-to-severe atopic dermatitis – Post hoc analyses from the ARCADIA long-term extension trial
Thaçi D, Tauber M, Papp K, De Bruin-Weller M, Augustin M, Barbarot S, Cheong SY, Ryzhkova A, Ulianov L, Piketty C
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczemaItch & prurigo
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1155 · Not in PubMed: details from Crossref